Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol for post-cesarean pain relief and prevention of postpartum depression
ChiCTR1900024930Phase 4Recruiting
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of butorphanol in postpartum depression (PPD) and postoperative pain (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoints: Edinburgh Postnatal Depression Scale and sleep duration. Started Aug 2019; status: recruiting.
02
Drugs
butorphanol
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR1900024930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024930.